CoChat

The DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index.

Methylphenidate Dosage for Children With ADHD Over Time Under Controlled Conditions: Lessons From the MTA

Abstract

Objectives To examine the trajectory of methylphenidate (MPH) dosage over time, following a controlled titration, and to ascertain how accurately the titration was able to predict effective long-term treatment in children with attention-deficit/hyperactivity disorder (ADHD).Method Using the 14-month-treatment database of the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA), the outcome of the initial placebo-controlled, double-blind, randomized daily switch titration of MPH was compared with the subsequent maintenance pharmacotherapy. Children received monthly monitoring visits and, when needed, medication adjustments.Results Of the 198 children for whom MPH was the optimal treatment at titration (mean +/- SD dose: 30.5 +/- 14.2 mg/day), 88% were still taking MPH at the end of maintenance (mean dose 34.4 +/- 13.3 mg/day). Titration-determined dose and end-of-maintenance dose were significantly correlated (r = 0.52-0.68). Children receiving combined pharmacotherapy and behavioral treatment ended maintenance on a lower dose (31.1 +/- 11.7 mg/day) than did children receiving pharmacotherapy only (38.1 +/- 14.2 mg/day). Of the 230 children for whom titration identified an optimal treatment, 17% continued both the assigned medication and dosage throughout maintenance. The mean number of pharmacological changes per child was 2.8 +/- 1.8 (SD), and time to first change was 4.7 months +/- 0.3 (SE).Conclusions For most children, initial titration found a dose of MPH in the general range of the effective maintenance dose, but did not prevent the need for subsequent maintenance adjustments. For optimal pharmacological treatment of ADHD, both careful initial titration and ongoing medication management are needed.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004583-200102000-00013

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Research works printed but not linked: 1

  1. Ghosh K, Kramer M (1999), A review of placebo-controlled efficacy trials for antidepressants as evaluated by the FDA. Poster presentation at the NCDEU 39th Annual Meeting, Boca Raton, FL, June 1–4

Cited by

See all 163

Metadata

Authors
VITIELLO, B., SEVERE, J. B., GREENHILL, L. L., ARNOLD, L. E., ABIKOFF, H. B., BUKSTEIN, O. G., ELLIOTT, G. R., HECHTMAN, L., JENSEN, P. S., HINSHAW, S. P., MARCH, J. S., NEWCORN, J. H., SWANSON, J. M., & CANTWELL, D. P.
Affiliations
  • National Institutes of Health (US)
  • University of Pittsburgh (US)
Corresponding author
VITIELLO, BENEDETTO
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2001-02
Volume
40
Issue
2
Pages
188-196
ISSN
0890-8567 (ISSN-L)
OpenAlex
W2016267343
Cited by
163
References
19
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 5 · 2017: 5 · 2016: 9 · 2015: 6 · 2014: 2 · 2013: 4 · 2012: 6
FWCI
5.80
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Funders
National Institute of Mental Health (UO1 MH50453, UO1 MH50461, U01MH064869, U01MH064868, UO1 MH-50454, UO1 MH50440, U01MH050467, U01MH050447, U01MH050440, UO1MH50467, U01MH050453, U01MH064911, UO1 MH50447, U01MH050461, U01MH050454)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
Keywords
methylphenidate, attention deficit hyperactivity disorder, dose titration, maintenance pharmacotherapy, treatment response prediction, medication management
MeSH terms
Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Male, Methylphenidate, North America, Time Factors, Comorbidity, Survival Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Methylphenidate Dosage for Children With ADHD Over Time Under Controlled Conditions: Lessons From the MTA. https://app.cochat.ai/papers/10.1097/00004583-200102000-00013
The paper
VITIELLO, B., SEVERE, J. B., GREENHILL, L. L., ARNOLD, L. E., ABIKOFF, H. B., BUKSTEIN, O. G., ELLIOTT, G. R., HECHTMAN, L., JENSEN, P. S., HINSHAW, S. P., MARCH, J. S., NEWCORN, J. H., SWANSON, J. M., & CANTWELL, D. P. (2001). Methylphenidate Dosage for Children With ADHD Over Time Under Controlled Conditions: Lessons From the MTA. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/00004583-200102000-00013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.